Forbes December 19, 2024
Juergen Eckhardt

It is now 12 months since the Food and Drug Administration rolled out the historic approval of a CRISPR therapy designed for patients suffering from sickle cell anemia and the blood disorder beta thalassemia.

From reprogrammed stem cells to next-generation gene editing, 2024 has seen some incredible developments with the potential to become new treatments for a range of chronic and inherited diseases.

Here are five new breakthroughs which I feel will hold the most promise in the years to come.

Groundbreaking Stem Cell Treatment Restores Vision

The fragile layers of cells that cover the cornea, the dome-shaped, outermost layer of the eye, can easily be damaged by burns, infections, inflammatory diseases of the eye and even side effects of...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma / Biotech
Gene Therapy Shows Long-Term Vision Benefits in Rare Eye Disease
A Biologist Explains The ‘Weird’ Habits Of People Who Live To 100+ Years Old
U.S. Health Care Spending Reaches $4.9 Trillion
Medicaid spending on weight loss, diabetes drugs up 500% since 2019: 5 numbers to know
FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.

Share This Article